secwatch.observer — SEC 8-K summary
======================================

Issuer:     Baudax Bio, Inc. (—)
CIK:        0001780097
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0001193125-24-049000
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03
LLM model:  deepseek-v4-flash:cloud@v2

Baudax Bio files Chapter 11 bankruptcy on February 22, 2024
-----------------------------------------------------------

- Filed voluntary Chapter 11 petition in U.S. Bankruptcy Court for Eastern District of Pennsylvania (case #2:24-bk-10583).
- Company intends to operate as debtor-in-possession during the case.
- No additional details regarding restructuring plan or financing provided in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1780097/000119312524049000/0001193125-24-049000-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1780097/000119312524049000/d800225d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-049000

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer